Sat.Dec 04, 2021 - Fri.Dec 10, 2021

A serial biotech entrepreneur launches his next startup with high-dollar backing

Bio Pharma Dive

Founded and led by Gary Glick, Odyssey Therapeutics has raised $218 million in an initial fundraising round for its cancer and inflammatory disease drug research

Drugs 277

Biogen: This train wreck was due

World of DTC Marketing

MY POINT : Success is always temporary. When all is said and one, the only thing you’ll have left is your character. Right now, I could make a great argument that Biogen’s character is trashed and that they are a company in dire need of authentic leadership.

Drugs 188

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

In the News: November 2021 Regulatory and Development Updates


Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Voxzogo Approved as a Growth-Improvement Therapy for Children with Dwarfism.

Crucial leap in error mitigation for quantum computers


Lessons in Supply Chain Digitization from PepsiCo and Conagra

Speaker: Craig Weiss, ConAgra Brands; Mari Roberts PepsiCo; and Matt Elenjickal, FourKites

Supply chain digitalization is key to success as market volatility, widespread disruption & stiff competition for consumer dollars puts pressure on every aspect of the supply chain. Register to hear how 2 global brands are accelerating digital transformation and increasing efficiency & automation throughout their operations.

A high-profile gene therapy biotech takes aim at Huntington's

Bio Pharma Dive

Passage Bio and the University of Pennsylvania's Gene Therapy Program said they have begun preclinical research aimed at simultaneously developing multiple approaches to treating Huntington's

Do you have enough money to launch your drug?

World of DTC Marketing

LEAD IN: Pharma budgets are being scrutinized like never before, and DTC/HCP marketers must justify every dollar spent.

More Trending

3D imaging method may help doctors better determine prostate cancer aggressiveness


Prostate cancer is the most common cancer for men and, for men in the United States, it’s the second leading cause of death. Some prostate cancers might be slow-growing and can be monitored over time whereas others need to be treated right away.

Fresh data show UniQure's hemophilia gene therapy appears to hold up

Bio Pharma Dive

The amount of blood clotting protein found in patients who received the medicine was nearly the same at six months and 18 months post-treatment, according to results disclosed Thursday

How much should I spend on an HCP website?

World of DTC Marketing

LEAD-IN- Recent data confirms that health care professionals are using the Internet more and spending less time with drug company reps. How much should you spend on an HCP portal, and how do you measure its success?

Is artificial intelligence the best tool for drug discovery?

Outsourcing Pharma

According to a leader from Cytoreason, AI isnât necessarily the best or only tool suited to discover new and novel therapiesâit might take a human touch. Preclinical Research

Drugs 114

3 Ways End-to-End Visibility Helps Minimize the Risks of Ocean Freight

Download this playbook to learn how end-to-end visibility helps to mitigate risk associated with the ocean freight market.

Innovative silicon nanochip can reprogram biological tissue in living body


A silicon device that can change skin tissue into blood vessels and nerve cells has advanced from prototype to standardized fabrication, meaning it can now be made in a consistent, reproducible way.

Vaccine from Medicago, GSK protective against COVID-19 in large study

Bio Pharma Dive

The vaccine, which Medicago plans to soon submit to Canadian regulators, would be the first of its type, though supply appears likely to be limited

Digital pill tracks HIV PrEP adherence with 98% accuracy

Pharma Phorum

A digital pill that records when it is taken has been shown to be highly effective at helping patients adhere to pre-exposure prophylaxis (PrEP) treatment used to protect them from contracting HIV.

ACT for ALS Passes House while BrainStorm Prepares Moves Ahead with NurOwn


Congress subcommittee unanimously approved the ACT for ALS bill in a decision that could soon pour massive funding into the search for treatment for this debilitating and deadly disease


4 Silver Linings of the Chaotic Ocean Freight Market

Speaker: Peter Tirschwell, Chris Stauber, Sarah Barnes Humphrey, and Audrey Ross

Join this webinar exploring the silver linings that have emerged from the chaotic ocean freight market. The discussion will highlight solutions that prioritize digitization and build a more efficient international supply chain. Jan 25 at 10am CT.

MicroRNAs: Biological indicators of the physiological status of animals


Known to be fine regulators of gene expression, microRNAs are small molecules that remain particularly stable in biofluids—blood, urine, etc.

Latest Roche results show promise for new type of cancer immunotherapy

Bio Pharma Dive

Updated Phase 2 data suggested an experimental drug targeting the protein TIGIT could bolster the benefit of Roche's Tecentriq in certain people with advanced lung cancer

Digital health firm Pear goes public, raising $175 million

Pharma Phorum

Pear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing and raising $175 million in gross proceeds for the digital health specialist.

Cambya Sugar Substitute Lets People Have Their Cake and Eat it Too


Sweet, an Israeli food tech startup, recently unveiled a plant-based, one-to-one drop-in sugar substitute called Cambya. It can replace sugar in a multitude of applications in the chocolate and confectionary space, boasting the same levels of sweetness and body as real sugar.

The Smart Data Revolution: How AB InBev Drives Efficiency with Visibility Data

Speaker: AB InBev and FourKites

Register for our upcoming webinar to learn how leveraging the right data to make quick, well-informed decisions is the key to success in supply chain & logistics. Join FourKites and AB InBev to learn what’s possible with a data-driven supply chain strategy & real-time transportation visibility.

Atom laser creates reflective patterns similar to light


Cooled to almost absolute zero, atoms not only move in waves like light but also can be focused into shapes called caustics, similar to the reflecting or refracting patterns light makes on the bottom of a swimming pool or through a curved wine glass.


Lilly deepens research ties in China with biotech deal

Bio Pharma Dive

The collaboration with Regor Therapeutics is another example of large pharma companies' interest in partnering with emerging biotechs from China

AZ’s antibody first to be cleared by FDA for COVID prevention

Pharma Phorum

AstraZeneca’s antibody cocktail for COVID-19, now called Evushield, has become the first drug in the class to be authorised for prevention of infection by the US FDA.

Report: Biogen Eyes Massive Layoffs in Wake of Disappointing Aduhelm Rollout


The company could lay off as many as 1,000 employees as it continues to deal with the controversial treatment


Modernizing Pharmaceutical Supply Chains

Speaker: Nimesh Patel, Gregory Demitrack, and Sarah Barnes Humphrey

Register for our upcoming webinar to better understand the state of the pharmaceutical supply chain. FourKites partnered with Accenture to survey supply chain executives working in pharmaceuticals, biotech, cell and gene therapy, medtech, and other related industries.

UTSW pharmacologists identify potential cure for tropical parasitic disease found in soil


Combining two agents to block a parasitic worm’s life cycle boosted survival from a potentially deadly tropical disease to 85% in animal models, far better than either treatment alone, according to a proof-of-concept study led by UT Southwestern Medical Center pharmacologists.

AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug

Bio Pharma Dive

The alliance follows AstraZeneca's buyout of Alexion last year and puts the British drugmaker in competition with Alnylam, Bridgebio and several others

Drugs 257

AI-based drug discovery firm BenevolentAI cuts SPAC deal

Pharma Phorum

UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal.

New Study: Fat Cells Are a Reservoir for COVID-19 Infection


Researchers published a study proving that SARS-CoV-2 infects human adipose or fat tissue to multiply and elicit an inflammatory response corresponding with severe COVID-19

Minimizing Retail Supply Chain Disruptions in 2021 and Beyond

Speaker: Izaac Moran, Customer Success Manager, FourKites; Glenn Koepke, SVP of Customer Success, FourKites; and featuring interviews with supply chain experts from Dollar Tree and Best Buy

Register for our upcoming webinar to see how savvy retailers including Dollar Tree and Best Buy are leveraging real-time visibility across their end-to-end supply chains in creative ways to drive agility and thrive in today’s unpredictable environment.

Disrupting flow of wood from rivers to oceans impacts marine environments


Ellen Wohl has always been fascinated by what happens in the deep sea. She studies interactions between rivers and water, the flow of sediment and wood, and the landforms created as a result.


Martin Shkreli's former company to pay $40M in settlement over drug price hikes

Bio Pharma Dive

The payment resolves the government's claims against Vyera and Phoenixus for their efforts to block competition to Daraprim, the toxoplasmosis drug Shkreli famously raised the price of by 4,000

Drugs 247

Valneva focuses its sights on the EU for its inactivated COVID-19 vaccine candidate

BioPharma Reporter

The European Medicines Agency (EMA) has started a rolling review of VLA2001, Valnevaâs COVID-19 vaccine candidate, with the company set to supply up to 60 million doses to the European Union. Markets & Regulations

Flashfood App Helps Users Save on Groceries and Keep Food Out of Landfills


Flashfood, a Toronto, Canada-based startup, is making it easier for consumers to save on groceries while simultaneously preventing unbought food from ending up in landfills.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.